1. Home
  2. NTST vs ZLAB Comparison

NTST vs ZLAB Comparison

Compare NTST & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NetSTREIT Corp.

NTST

NetSTREIT Corp.

HOLD

Current Price

$19.66

Market Cap

2.0B

Sector

Real Estate

ML Signal

HOLD

Logo Zai Lab Limited

ZLAB

Zai Lab Limited

HOLD

Current Price

$17.14

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NTST
ZLAB
Founded
2019
2013
Country
United States
China
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.0B
IPO Year
2020
2017

Fundamental Metrics

Financial Performance
Metric
NTST
ZLAB
Price
$19.66
$17.14
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
14
5
Target Price
$22.02
$49.60
AVG Volume (30 Days)
1.1M
795.4K
Earning Date
04-20-2026
05-07-2026
Dividend Yield
4.28%
N/A
EPS Growth
150.00
38.46
EPS
0.06
N/A
Revenue
$195,006,000.00
$460,156,000.00
Revenue This Year
$19.03
$9.75
Revenue Next Year
$16.25
$26.03
P/E Ratio
$332.67
N/A
Revenue Growth
19.79
15.33
52 Week Low
$16.04
$15.96
52 Week High
$21.30
$44.34

Technical Indicators

Market Signals
Indicator
NTST
ZLAB
Relative Strength Index (RSI) 37.24 33.77
Support Level $17.67 $15.96
Resistance Level $21.13 $19.64
Average True Range (ATR) 0.33 0.68
MACD -0.11 -0.20
Stochastic Oscillator 0.00 15.71

Price Performance

Historical Comparison
NTST
ZLAB

About NTST NetSTREIT Corp.

Netstreit Corp is an internally managed real estate investment trust. The company acquires, owns, and manages single-tenant, retail commercial real estate subject to long-term net leases with high-credit quality tenants across the United States. It focuses on tenants in industries where a physical location is critical to the generation of sales and profits, with a focus on necessity goods and essential services in the retail sector, including home improvement, auto parts, drug stores and pharmacies, general retail, grocers, convenience stores, discount stores, and quick-service restaurants. Majorily operates in U.S. States and Other counties, and derives maximum of revenue from USA.

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.

Share on Social Networks: